Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions.
AstraZeneca PLC continued its multi-year spree of mature asset divestitures on 3 December, selling off US and Canadian commercial...








